OneMedNet (NASDAQ:ONMD) reported today that it has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation...
Closely-held Cytel, a global leader in clinical trial design and software, announced today its strategic partnership with OneMedNet (NASDAQ:ONMD) to enhance data-driven healthcare solutions. The partnership will...
OneMedNet (NASDAQ:ONMD) announced that it has entered into a significant iRWD customer data licensing agreement, partnering with an undisclosed U.S.-based global leader in clinical trial design and software with...
OneMedNet (NASDAQ:ONMD) announced that it has joined the Amazon Web Services (AWS) Partner Network (APN), significantly expanding industry access to its proprietary iRWD platform and securing an undisclosed...
OneMedNet (NASDAQ:ONMD) is delivering seamless access to regulatory-grade imaging real-world data (RWD) by employing its proprietary iRWD network and platform to de-identify, search, and curate data revealing an...
OneMedNet (NASDAQ:ONMD) has entered into a non-exclusive three-year MSA with an undisclosed U.S.-based medical technology company that affects more than 150 million patients worldwide annually. OneMedNet will utilize...
OneMedNet’s (Nasdaq:ONMD) stock rallied over 208% on more than 420 times average trading volumes today after reporting a greater than five-fold expansion of its proprietary iRWD network and platform through a series of...